Senti Biosciences Holdings, Inc. (SNTI)

NASDAQ: SNTI · Real-Time Price · USD

0.3770

-0.0005 (-0.13%)

At close: Aug 28, 2026, 4:00 PM EDT

0.3946

+0.0176 (4.67%)

After-hours: Aug 28, 2026, 7:59 PM EDT

SNTI Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.46	16.42	48.28	35.93	57.62	56.03
Short-Term Investments	0.14	0.32	0.34	0.04	42.15	1.16
Cash & Short-Term Investments	6.61	16.74	48.61	35.97	99.77	57.19
Cash Growth	-69.51%	-65.57%	35.15%	-63.95%	74.45%	87.13%
Accounts Receivable	-	0.32	-	0.11	0.63	0.48
Other Receivables	0.56	1.27	1.81	17.59	-	-
Receivables	0.56	1.6	1.81	17.7	0.63	0.48
Prepaid Expenses	5.56	4.94	7.96	17.33	1.87	0.8
Other Current Assets	0.29	-	0.58	0.2	0.31	1.72
Total Current Assets	13.01	23.27	58.96	71.2	102.58	60.19
Property, Plant & Equipment	18.67	24.4	35.24	41.61	69.78	33.08
Other Long-Term Assets	1.43	3.55	3.64	6.67	8.43	3.43
Total Assets	33.11	51.22	97.84	119.48	180.79	96.7

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.25	2.94	1.45	1.25	1.37	5.19
Accrued Expenses	3.57	5.28	5.95	5.93	12.58	5.33
Current Portion of Leases	3.49	5.33	4.65	4.13	1.99	1.74
Current Unearned Revenue	1.95	0.35	0.66	0.99	0.8	1.66
Other Current Liabilities	0.51	0.07	0.43	0.38	1.32	0.63
Total Current Liabilities	15.77	13.97	13.15	12.67	18.05	14.54
Long-Term Leases	12.74	23.56	28.89	33.54	35.1	20.99
Long-Term Unearned Revenue	8	7.95	4.9	-	-	0.18
Other Long-Term Liabilities	-	0.15	0.15	6.36	0.37	0.62
Total Liabilities	36.51	45.63	47.09	52.57	53.53	36.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	-
Additional Paid-In Capital	372.14	364.16	322.78	311.26	300.54	3.62
Retained Earnings	-375.54	-358.57	-297.13	-244.34	-173.29	-115.08
Comprehensive Income & Other	-	-	-	-	0	-
Total Common Equity	-3.4	5.59	25.65	66.91	127.26	-111.46
Shareholders' Equity	-3.4	5.59	50.76	66.91	127.26	60.38
Total Liabilities & Equity	33.11	51.22	97.84	119.48	180.79	96.7

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	20.23	28.89	33.54	37.67	37.09	22.73
Net Cash (Debt)	-13.62	-12.16	15.07	-1.7	62.68	34.46
Net Cash Growth	-	-	-	-	81.89%	108.68%
Net Cash Per Share	-0.47	-0.54	3.28	-0.38	24.01	118.33
Filing Date Shares Outstanding	31.14	31.14	26	4.57	4.42	1.52
Total Common Shares Outstanding	31.14	30.88	4.83	4.57	4.41	1.52
Working Capital	-2.76	9.3	45.82	58.53	84.53	45.65
Book Value Per Share	-0.11	0.18	5.31	14.64	28.88	-73.38
Tangible Book Value	-3.4	5.59	25.65	66.91	127.26	-111.46
Tangible Book Value Per Share	-0.11	0.18	5.31	14.64	28.88	-73.38
Machinery	7.93	8.2	8.18	8.87	8.56	5.54
Construction In Progress	-	-	-	-	43.89	8.05
Leasehold Improvements	17.75	17.75	22.66	22.65	1.87	0.43

SEC Filings: 10-K · 10-Q